Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.
about
Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study.
P2860
Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and immunogenicity of 1 ...... ns in the second year of life.
@ast
Safety and immunogenicity of 1 ...... ns in the second year of life.
@en
Safety and immunogenicity of 1 ...... ae protein D conjugate vaccine
@nl
type
label
Safety and immunogenicity of 1 ...... ns in the second year of life.
@ast
Safety and immunogenicity of 1 ...... ns in the second year of life.
@en
Safety and immunogenicity of 1 ...... ae protein D conjugate vaccine
@nl
prefLabel
Safety and immunogenicity of 1 ...... ns in the second year of life.
@ast
Safety and immunogenicity of 1 ...... ns in the second year of life.
@en
Safety and immunogenicity of 1 ...... ae protein D conjugate vaccine
@nl
P2093
P2860
P356
P1476
Safety and immunogenicity of 1 ...... ns in the second year of life.
@en
P2093
Dorota Borys
Fakrudeen Shafi
Jens U Rüggeberg
Kurt Dobbelaere
Lode Schuerman
Nancy François
Olumuyiwa O Odusanya
Omolara A Kehinde
Yetunde A Kuyinu
P2860
P304
P356
10.4161/HV.27276
P577
2013-12-04T00:00:00Z